Stephen Faraone, PhD, is a Distinguished Professor in the Departments of Psychiatry and Neuroscience & Physiology at SUNY Upstate Medical University and Director of Research for the Department of Psychiatry.  He is also Senior Scientific Advisor to the Research Program Pediatric Psychopharmacology at the Massachusetts General Hospital and a lecturer at Harvard Medical School.  Prof. Faraone studies the nature and causes of mental disorders in childhood and has made contributions to research in psychiatric genetics, psychopharmacology, diagnostic issues and methodology.

An author on over 1000 journal articles, editorials, chapters and books, in 2005, the Institute for Scientific Information determined him to be the second highest cited author in the area of Attention Deficit Hyperactivity Disorder (http://www.esi-topics.com/add/interviews/StephenFaraone.html)  and the fourth most highly cited researcher in psychiatry (http://in-cites.com/top/2005/first05-psy.html) for the preceding decade. From 2014 to 2019 he has been listed as a highly cited researcher by Thomson Reuters/Clarivate Analytics.  In 2019, his citation metrics placed him in the top 0.01% of scientists across all fields http://tinyurl.com/y39c25sa.  His lifetime H-Index as of March 2020 was 208.

Prof. Faraone is Editor for the journal Neuropsychiatric Genetic and Program Director of the educational website www.adhdinadults.com.  He is President of the World Federation for ADHD and a Board member for the American Professional Society of ADHD and Related Disorders.  He founded the ADHD Molecular Genetics Network in the 1990s and was a founding member of the Psychiatric Genomics Consortium’s Coordinating Committee. 

In 2002, Prof. Faraone was inducted into the CHADD Hall of Fame in recognition of outstanding achievement in medicine and education research on attention disorders.  In 2008, he received the SUNY Upstate President’s Award for Excellence and Leadership in Research.  In 2009 he was awarded Alumni Fellow status at the University of Iowa in recognition of his outstanding contributions to society and his profession. In 2010 he received the Chancellor's Award for Excellence in Scholarship and Creative Activities from the State University of New York. In 2013, he was awarded the title of Distinguished Professor by the State University of New York, which is conferred upon faculty having achieved national or international prominence and a distinguished reputation within the individual’s chosen field. In 2018 he received the Lifetime Achievement Award from the International Society of Psychiatric Genetics and in 2019 he received the Paul Hoch Award from the American Psychopathological Association.  

Professor emeritus of Psychotherapy at the Department of Child and Adolescent Psychiatry, Psychosomatic and Psychotherapy, Medical Faculty
and Faculty of Human Sciences of the University of Cologne, Germany.

Professor Dr. Doepfner began his career with a Psychology degree at the University of Mannheim. Germany. In 1990, he received his doctorship from the University of Heidelberg’s Faculty of Medicine. He is supervisor of behaviour therapy and Head of the School or Child and Adolescent Cognitive Behavior Therapy (AKiP) at the University of Cologne. He received the German Psychology Prize for his scientific work in 2005.

His main research interests are assessment, prevention, and treatment of ADHD, Conduct Disorders, Anxiety Disorders, Obsessive-Compulsive Disorders and Tic Disorders. He is principal investigator of several multicentre trials on pharmacotherapy and psychotherapy of ADHD and conduct disorders, of prevention studies for externalizing problem behaviour in children, and on self-help-interventions for parents of children and adolescents with ADHD/ODD.

Prof. em. Manfred Doepfner, PhD
Department for Child and Adolescent Psychiatry, Psychosomatic and Psychotherapy
School for Child and Adolescent Cognitve Behavior Therapy
University of Cologne
Pohligstr. 9, D-50969 Koeln, Germany
manfred.doepfner@uk-koeln.de
 

Diane Purper-Ouakil is professor of child and adolescent psychiatry at the university hospital of Montpellier, France. Since 2011, she is head of the child and adolescent unit of the Saint Eloi Hospital. This unit has facilities for both inpatient and outpatient care for young patients and has specialized services for children and adolescents with ADHD and eating disorders.
She is also vice-president of the faculty college of psychiatry involved in the ongoing reform of the training curriculum of medical studies and is member of the professional college of psychiatrists. 
Diane Purper-Ouakil aims to develop the evidence-base of psychological, neurophysiological and pharmacological treatments, especially for children and adolescents with challenging and enduring behavioural and emotional symptoms. She is involved in collaborative treatment studies, some assessing parent programs, an important feature of comprehensive treatment plans for young people with complex needs. 

 

Alexandra Philipsen, MD. Since 2018 Director and W3 Professor of the Department of Psychiatry and Psychotherapy, University of Bonn. Since 2021 Deputy Medical Director of the University Hospital Bonn. 2014-2017 Director and W3 Professor of the Dept. of Psychiatry and Psychotherapy, Karl Jaspers Klinik, European Medical School, Oldenburg-Groningen.

2009-2014 Executive Senior Physician, Department of Psychiatry and Psychotherapy, University of Freiburg. 2009 Habilitation "on the etiology, symptomatology and therapy of attention-deficit/hyperactivity disorder in adults". 1999 Dr. med. "Botulinum toxin A as a new therapy option in neuropaediatrics, University of Freiburg.

Supervisor for cognitive behavior therapy, dialectical behavior therapy. Scientific focus: translational therapy research on attention and emotion regulation, development and evaluation of pharmacological and non-pharmacological treatments for ADHD in adults. Clinical focus: diagnosis and treatment of the entire spectrum of mental disorders, especially affective disorders such as depression, stress-associated disorders, ADHD in adulthood and personality disorders, crisis intervention and suicidality. Scientific advisor of ADHS-Deutschland (https://adhs-deutschland.de/Home.aspx), member of the steering board of the German ADHD Network (www.zentrales-adhs-netz.de).

Benedetto Vitiello, M.D. is a psychiatrist and pediatrician with expertise in psychopharmacology and treatment research.  A graduate of the University of Pavia Medical School, Pavia, Italy, he trained in pediatrics in Italy and in psychiatry and child and adolescent psychiatry in the U.S.A.  From 1989 until 2016, he worked at the National Institutes of Health in Bethesda, Maryland, U.S.A., where he was Chief of the Child and Adolescent Treatment and Preventive Interventions Research Branch of the National Institute of Mental Health.  From 2007, he is adjunct Professor in the Mental Health Department of the Johns Hopkins University School of Public Health, in Baltimore, U.S.A.  From 2016, he is Professor of Child and Adolescent Neuropsychiatry at the University of Turin, Italy. His research has focused on developing and testing effective treatment and preventive interventions for children, adolescents, and adults with mood and anxiety disorders, psychosis, attention deficit/hyperactivity disorder, autism, and other neurodevelopmental disorders.  He has contributed more than 350 scientific publications to the field of mental health.

CURRENT APPOINTMENTS

• Professor of Child and Adolescent Neuropsychiatry, University of Turin, Italy 
• Professor (adjunct), Johns Hopkins University, Department of Mental Health, School of Public Health, Baltimore, Maryland, U.S.A.
• Director of Child and Neuropsychiatry Services at the University of Turin Children’s Hospital “Regina Margherita” in Turin, Italy.
   

Saskia van der Oord is a full professor in Clinical Child Psychology at the Faculty of Psychology and Educational Sciences of the KU Leuven, also she is a clinical psychologist and behavior therapist. Her research is focused on examining effectiveness of psychological interventions for children and adolescents with ADHD, and unraveling intervention mechanisms and moderators in children and adolescents with ADHD. Also, more fundamental research on motivational alterations in ADHD is one of her core research areas.

 

Dora Wynchank works as a psychiatrist and researcher at the Intensive Specialist Programme for ADHD and as a researcher at the Expertise Centre, ADHD, The Hague. Originally from South Africa, in August 2014 she relocated with her family to The Netherlands, where she completed a PhD on adult ADHD and biological rhythms, at the Free University of Amsterdam. She has researched, published widely and presented her research internationally. She is also editor of the DIVA Foundation. The DIVA is a diagnostic interview for the diagnosis of ADHD, available in 30 languages. Her current research interests include ADHD in women.

 

Mat Rawsthorne CGMA received his ADHD diagnosis in 2020 after repeated episodes and a variety of treatments for depression. He began his career in business intelligence, supporting decision makers in a range of public, private and third sector organisations, changing jobs frequently. He attended and then became a founder and eventually professional trainer of self help groups. He got involved in research initially as a participant, and then as a facilitator, encouraging other patients to help shape priorities. His interest in online peer support led him to undertaking doctoral training in a study to understand predictors of engagement. He now works as Head of Research for HD Labs, a digital health firm specialising in data orchestration and application codesign to improve care and personalise interventions for people with long term conditions. He also helps facilitate a mutual aid group for parents of neurodiverse children.

 

Blandine works in clinical and research environments primarily with parents, children and young people with developmental disorders. She completed her PhD in Applied Psychology at the University of Nottingham, investigating the awareness and understanding of ADHD in primary care. She specifically developed and evaluated an online educational tools coproduced with GPs to increase their awareness of ADHD. This online training was endorsed by the RCGP and the leading GP training company, FourteenFish. Blandine has worked with parents of children with ADHD and adult patients for the last decade, running peer support groups. She also received a diagnosis of ADHD as an adult which enabled her to go back to university to gain a degree in child psychology as a mature student.

 

Diagnosed in 2017 at the age of 44 after a suicidal crisis, Michelle then became an advocate for reducing stigma and widening understanding of ADHD through the charity she founded, ADHD Action. She then turned her many years experience as a business and mindset coach, mentor, and trainer to support others with the condition, through her social enterprise The ADHD Collective. Michelle also trains and coaches charities, psychiatrists, GPs, teachers, and social workers on ADHD. Michelle is a frequent media spokesperson on ADHD. Recent appearances include BBC Victoria Derbyshire, BBC Radio 4, Radio 5 Live, LBC, The Times, The Mirror, Women’s Health, SEN Magazine, Additude Magazine, and The Guardian. Michelle co-authored the UK scientific consensus paper for females with ADHD published in BMC Psychiatry in 2020, and spearheaded the All Party Parliamentary Group for ADHD, earning a commendation in Hansard – the official parliamentary record – for her advocacy and lobbying work.

 

Contact details
Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Postbox: 12 21 20, D-68072 Mannheim/Germany

 

 

 

Education and professional experience

1979 – 1993	Studies of psychology and medicine at the University Marburg, Germany
1993 – 1995	Resident in Adult Psychiatry; Marburg, Germany
1997	MD Medicine, University of Marburg
1995 –1999	Resident in Child Psychiatry, University of Göttingen, Germany
1999 – 2002	Scientific associate, Department of Child and Adolescent Psychiatry, University of Göttingen, Germany
2002	Deputy director of the Department of Child and Adolescent Psychiatry, University of Göttingen, Germany
2004	Habilitation, Child and Adolescent Psychiatry and Psychotherapy, University of Göttingen, Germany
2004	PhD Psychology, University of Göttingen
2006 – current	Professor of Child and Adolescent Psychiatry at the Medical Faculty Mannheim of the University of Heidelberg and Medical Director of the Department of Child and Adolescent Psychiatry of the Central Institute of Mental Health in Mannheim, Germany
2014 – current	Deputy Director of the Central Institute of Mental Health, Germany

Research areas

• Psychopathology, neuropsychology, neurophysiology, and psychopharmacology of ADHD and comorbid disorders

Awards

• Kramer-Pollnow Award 2003 
• August-Homburger Award 2014
• Saarländischer ADHS-Forschungspreis (ADHD Research Award) 2016